S M Plum
Overview
Explore the profile of S M Plum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fortier A, Holaday J, Liang H, Dey C, Grella D, Holland-Linn J, et al.
Prostate
. 2003 May;
56(3):212-9.
PMID: 12772191
Background: Prostate specific antigen (PSA) is a kallikrein family member with serine protease activity commonly used as a diagnostic marker for prostate cancer. We recently described anti-angiogenic properties of PSA...
2.
Macdonald N, Shivers W, Narum D, Plum S, Wingard J, Fuhrmann S, et al.
J Biol Chem
. 2001 May;
276(27):25190-6.
PMID: 11335715
The mechanism of action of Endostatin, an endogenous inhibitor of angiogenesis and tumor growth, remains unknown. We utilized phage-display technology to identify polypeptides that mimic the binding domains of proteins...
3.
Liu N, Lapcevich R, Underhill C, Han Z, Gao F, SWARTZ G, et al.
Cancer Res
. 2001 Feb;
61(3):1022-8.
PMID: 11221828
In this study, a hyaluronan-binding complex, which we termed Metastatin, was isolated from bovine cartilage by affinity chromatography and found to have both antitumorigenic and antiangiogenic properties. Metastatin was able...
4.
Plum S, Holaday J, Ruiz A, Madsen J, Fogler W, Fortier A
Vaccine
. 2001 Jan;
19(9-10):1294-303.
PMID: 11137269
Basic fibroblast growth factor (FGF-2) is an important stimulator of angiogenesis that has been implicated in neoplastic progression. Attempts to neutralize or modulate FGF-2 have met with some success in...